|
PATRONES DE ANALISIS (DEHYDRO APIXABAN)
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
CANADA |
PANAMA |
1 |
|
1. HUMAN MEDICINES FOR THERAPEUTIC USE, PACKAGED FOR RETAIL TRADE (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, ALKALOIDS, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. ELIQUIS TABLETS, COVERED WITH A FILM COVER, 2.5 MG EACH 10 TABLETS IN A BLISTER, 2 BLISTERS IN A CARDBOARD PACKAGE/ 1 FILM-COATED TABLET CONTAINING 2.5 MG APIXABAN / BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY (MANUFACTURING, QUALITY CONTROL AND CONTROL QUALITIES AT THE RELEASE OF THE SERIES), USADINASTAT LYOPHILISATE FOR SOLUTION FOR INJECTION 40 MG, 10 VIALS WITH LYOPHILISATE IN A CARDBOARD BOX /1 VIAL CONTAINS 40 MG PARECOXIB AS PARECOXIB SODIUM 42.36 MG /PFEISER MANUFACTURING BELGIUM NV (SECONDARY PACKAGING, RELEASE SERIES), BELGIAPHARMACY AND UPJOHN COMPANY LLC ( MANUFACTURE IN BULK, PRIMARY PACKAGING), USA
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
UNITED STATES |
UKRAINE |
0 |
|
1. DRUGS FOR HUMANS, WITHOUT CONTENTS: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: ELIQUIS, FILM-COATED TABLETS, 5 MG EACH 10 TABLETS IN A BLISTER, 6 BLISTERS IN A CARDBOARD PACK / 1 FILM-COATED TABLET CONTAINS 5 MG APIXABAN; MANUFACTURER BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY (MANUFACTURING, QUALITY CONTROL AND QUALITY CONTROL AT SERIES RELEASE), USA/ CATALENT ANAGNI S.R.L. (PACKAGING, QUALITY CONTROL AND SERIES RELEASE), ITALY/ PFIZER MANUFACTURER URING DEUTSCHLAND GMBH (PACKAGING, BATCH RELEASE QUALITY CONTROL AND BATCH RELEASE), GERMANY/ PFIZER IRELAND PHARMACEUTICALS (MANUFACTURING, BATCH RELEASE QUALITY CONTROL), IRELAND/ SORDZ LABORATORIES T/A BRISTOL-MYERS SQUIBB PHARMACEUTICAL OPER EISHNZ, EXTERNAL MANUFACTURING (SERIES RELEASE), IRELAND; ELIFOR, TABLETS OF PROLONGED EFFECT OF 50 MG 14 TABLETS IN BLISTERS; 2 BLISTERS IN A CARDBOARD BOX / 1 EXTENDED-RELEASE TABLET CONTAINS DESVENLAFAXIN SUCCINATE IN AN AMOUNT EQUIVALENT TO 50 MG OF DESVENLAFAXIN; MANUFACTURER PFEZER PHARMACEUTICALS IRELAND (MANUFACTURING, PRIMARY AND SECONDARY PACKAGING, QUALITY CONTROL), IRELAND/PFEZER MANUFACTURING DEUTSCHLAND GMBH (PRIMARY AND SECONDARY PACKAGING, BATCH RELEASE), GERMANY
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
IRELAND |
UKRAINE |
0 |
|
1. MEDICINE FOR HUMAN PURPOSES, PACKAGED FOR RETAIL. SERIES HM5937: ELIQUIS, FILM-COATED TABLETS, 5 MG, 10 TABLETS IN BLISTERS; 6 BLISTERS IN A CARDBOARD PACKAGE - 2088 UNITS. (ACTIVE INGREDIENT - APIXABAN) MANUFACTURER: MANUFACTURING, QUALITY CONTROL AT BATCH RELEASE: PFIZER IRELAND PHARMACEUTICALS, IE; PACKAGING, QUALITY CONTROL AT BATCH RELEASE AND BATCH RELEASE: PFIZER MANUFACTURING DEUTSCHLAND GMBH, DE
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
IRELAND |
UKRAINE |
0 |
|
1. HUMAN MEDICINES, PACKAGED FOR RETAIL TRADE.SERIES HN1684:DINASTAT, LYOPHILISATE FOR SOLUTION FOR INJECTION 40 MG, 10 VIALS WITH LYOPHILISATE IN A CARDBOARD BOX - 108 UNITS.SERIES HK6847:DINASTAT, LYOPHILISATE ILYZATE FOR SOLUTION FOR IN' ECTION OF 40 MG, 5 VIALS WITH LYOPHILISATE IN A KIT WITH 5 AMPOULES OF SOLVENT OF 2 ML (SODIUM CHLORIDE, WATER FOR INJECTIONS) IN A CARTON BOX - 225 UNITS (ACTIVE INGREDIENT - SODIUM PARECOXIB) MANUFACTURER: MANUFACTURE IN BULK, ORIGINAL PACKAGING : PHARMACY AND APPLIANCE COMPANY LLC, US; SECONDARY PACKAGING, SERIES RELEASE; FOR SOLVENT - FULL CYCLE OF PRODUCTION AND ISSUE: PFIZER MANUFACTURING BELGIUM NV, BE. SERIES FY3320: ELIQUIS, FILM-COATED TABLETS, 2.5 MG, 10 TABLETS IN BLISTERS; 2 BLISTERS IN A CARDBOARD PACKAGE - 480 UNITS. (ACTIVE INGREDIENT - APIXABAN) MANUFACTURER: MANUFACTURING, QUALITY CONTROL AND QUALITY CONTROL AT BATCH RELEASE: BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY, US; PACKAGING, QUALITY CONTROL AT BATCH RELEASE AND BATCH RELEASE: PFIZER MANUFACTURING DEUTSCHLAND GMBH, DE
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
UNITED STATES |
UKRAINE |
0 |
|
1. HUMAN MEDICINES FOR THERAPEUTIC USE, PACKAGED FOR RETAIL (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, ALKALOIDS, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. ELIQUIS TABLETS, IN FILM-COVERED, 5 MG BY 10 TABLETS IN BLISTERS, 6 BLISTERS IN A CARDBOARD PACK / 1 FILM-COATED TABLET CONTAINING 5 MG OF APIXABAN / BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY (MANUFACTURING, QUALITY CONTROL AND QUALITY CONTROL AT SERIES RELEASE), USAPFIZER IRELAND PHARMACEUTICALS (MANUFACTURING, CONTROL QUALITIES AT BATCH RELEASE), IRELAND SORDS LABORATORIES T/A BRISTOL-MYERS SQUIBB PHARMACEUTICAL OPERATIONS, EXTERNAL MANUFACTURING (BATCH RELEASE), IRELAND PFIZER MANUFACTURING DEUTSCHLAND GMBH (PACKAGING, QUALITY CONTROL AT SERIES RELEASE AND SERIES RELEASE), GERMANY
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
IRELAND |
UKRAINE |
0 |
|
1. HUMAN MEDICINES, PACKAGED FOR RETAIL. SERIES HK6847: DINASTAT, LYOPHILISATE FOR SOLUTION FOR INJECTION 40 MG, 5 VIALS WITH LYOPHILISATE IN A KIT WITH 5 AMPOLES OF SOLVENT OF 2 ML (SODIUM CHLORIDE, WATER FOR INJECTIONS) IN A CARDBOARD BOX - 45 UNITS. (ACTIVE INGREDIENT - PARECOXIB SODIUM) MANUFACTURER: MANUFACTURE IN BULK, PRIMARY PACKAGING: PHARMACY AND APJON COMPANY LLC, US; SECONDARY PACKAGING, SERIES RELEASE; FOR SOLVENT - FULL CYCLE OF PRODUCTION AND ISSUE: PFIZER MANUFACTURING BELGIUM NV, BE. SERIES FY3320: ELIQUIS, FILM-COATED TABLETS, 2.5 MG, 10 TABLETS IN BLISTERS; 2 BLISTERS IN A CARDBOARD PACKAGE - 2400 UNITS. (ACTIVE INGREDIENT - APIXABAN) MANUFACTURER: MANUFACTURING, QUALITY CONTROL AND QUALITY CONTROL AT BATCH RELEASE: BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY, US; PACKAGING, QUALITY CONTROL AT BATCH RELEASE AND BATCH RELEASE: PFIZER MANUFACTURING DEUTSCHLAND GMBH, DE
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
UNITED STATES |
UKRAINE |
0 |
|
1. MEDICINE FOR HUMANS, PACKAGED FOR RETAIL TRADE. HJ6652 SERIES: ELIFOR, 50 MG EXTENDED-RELEASE TABLETS, 14 TABLETS IN BLISTERS; 2 BLISTERS IN A CARDBOARD BOX - 288 UNITS. (ACTIVE INGREDIENT - DESVENLAFAXIN) MANUFACTURER: MANUFACTURING, PRIMARY AND SECONDARY PACKAGING, QUALITY CONTROL: PFIZER IRELAND PHARMACEUTICALS, IE; PRIMARY AND SECONDARY PACKAGING, BATCH ISSUED: PFIZER MANUFACTURING DEUTSCHLAND GMBH, DE. SERIES HM5937: ELIQUIS, FILM-COATED TABLETS, 5 MG, 10 TABLETS IN BLISTERS; 6 BLISTERS IN A CARDBOARD PACKAGE - 720 UNITS. (ACTIVE INGREDIENT - APIXABAN) MANUFACTURER: MANUFACTURING, QUALITY CONTROL AT BATCH RELEASE: PFIZER IRELAND PHARMACEUTICALS, IE; PACKAGING, QUALITY CONTROL AT BATCH RELEASE AND BATCH RELEASE: PFIZER MANUFACTURING DEUTSCHLAND GMBH, DE
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
IRELAND |
UKRAINE |
0 |
|
1. HUMAN MEDICINES FOR THERAPEUTIC USE, PACKAGED FOR RETAIL TRADE (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, ALKALOIDS, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. ELIQUIS TABLETS , COVERED WITH A FILM COVER, 2.5 MG EACH 10 TABLETS IN BLISTERS, 2 BLISTERS IN CARDBOARD PACK / 1 FILM-COATED TABLET CONTAINING 2.5MG APIXABAN / BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY (MANUFACTURING, QUALITY CONTROL AND CONTROL I DONE AT SERIES RELEASE), USA/PFEISER MANUFACTURING DEUTSCHLAND GMBH (PACKAGING, QUALITY CONTROL AT BATCH RELEASE AND BATCH RELEASE), GERMANY DINASTAT LYOPHILISATE FOR SOLUTION FOR INJECTION 40 MG, 10 VIALS WITH LYOPHILISATE IN A CARDBOARD BOX/1 VIAL CONTAINS 40 MG PARECOXIB AS PARECOXIB SODIUM 42.36 MG /PHARMACY AND SUPPLY COMPANY LLC (MANUFACTURING IN BULK, PRIMARY PACKAGING), USA
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
UNITED STATES |
UKRAINE |
0 |
|
1. DRUGS FOR HUMANS, WITHOUT CONTENT OF VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: ELIQUIS, FILM-COATED TABLETS, 5 MG, 10 TABLETS IN BLIS TERI, 6 BLISTERS IN A CARDBOARD PACK / 1 FILM-COATED TABLET CONTAINS 5 MG OF APIXABAN; MANUFACTURED BY BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY (MANUFACTURING, QUALITY CONTROL AND QUALITY CONTROL AT BATCH RELEASE), USA/ CATALENT ANAGNI S.R.L.. (PACKAGING, QUALITY CONTROL AND RELEASE SERIES), ITALY/ PFIZER MANUFACTURING DEUTSCHLAND GMBH (PACKAGING, QUALITY CONTROL AT BATCH RELEASE AND BATCH RELEASE), GERMANY/ PFIZER IRELAND PHARMACEUTICALS (MANUFACTURING, QUALITY CONTROL AT BATCH RELEASE), IRELAND I/ SORDZ LABORATORIES T/A BRISTOL-MYERS SQUIBB PHARMACEUTICAL OPERATIONS , EXTERNAL MANUFACTURING (SERIES RELEASE), IRELAND
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
IRELAND |
UKRAINE |
0 |
|
1. DRUGS FOR HUMANS, WITHOUT VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: ELIQUIS, FILM-COATED TABLETS, 2.5 MG, 10 TABLETS IN BLISTERS, 2 BLISTERS IN A PACK OF CARTON / 1 FILM-COATED TABLET, CONTAINING 2.5 MG APIXABAN; MANUFACTURED BY BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY (MANUFACTURING, QUALITY CONTROL AND QUALITY CONTROL AT BATCH RELEASE), USA/ CATALENT ANAGNI S.R.L. (PACKAGING, QUALITY CONTROL AND BATCH RELEASE), ITALY/ PFIZER MANUFACTURING DEUTSCHLAND GMBH (PACKAGING, BATCH QUALITY CONTROL AND BATCH RELEASE), GERMANY/ PFIZER IRELAND PHARMACEUTICALS (MANUFACTURING, QUALITY CONTROL AT BATCH RELEASE), IRELAND/ SORDZ LABORATORIES T/A BRISTOL- MYERS SQUIBB PHARMACEUTICAL OPERATIONS, EXTERNAL MANUFACTURING (SERIES ISSUE), IRELAND
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
UNITED STATES |
UKRAINE |
0 |
|
1. DRUGS FOR HUMANS, WITHOUT CONTENT OF VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: ELIQUIS, FILM-COATED TABLETS, 5 MG, 10 TABLETS IN BLIS TERI, 6 BLISTERS IN A CARDBOARD PACK / 1 FILM-COATED TABLET CONTAINS 5 MG OF APIXABAN; MANUFACTURED BY BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY (MANUFACTURING, QUALITY CONTROL AND QUALITY CONTROL AT BATCH RELEASE), USA/ CATALENT ANAGNI S.R.L.. (PACKAGING, QUALITY CONTROL AND RELEASE SERIES), ITALY/ PFIZER MANUFACTURING DEUTSCHLAND GMBH (PACKAGING, QUALITY CONTROL AT BATCH RELEASE AND BATCH RELEASE), GERMANY/ PFIZER IRELAND PHARMACEUTICALS (MANUFACTURING, QUALITY CONTROL AT BATCH RELEASE), IRELAND I/ SORDZ LABORATORIES T/A BRISTOL-MYERS SQUIBB PHARMACEUTICAL OPERATIONS , EXTERNAL MANUFACTURING (SERIES RELEASE), IRELAND
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
IRELAND |
UKRAINE |
0 |
|
1. DRUGS FOR HUMANS, WITHOUT CONTENTS: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: ELIQUIS, FILM-COATED TABLETS, 2.5 MG EACH 10 TABLETS IN A BLISTER, 2 BLISTERS IN A PACKAGE FROM A CARTON / 1 FILM-COATED TABLET CONTAINING 2.5 MG APIXABAN; MANUFACTURED BY BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY (MANUFACTURING, QUALITY CONTROL AND QUALITY CONTROL AT BATCH RELEASE), USA/ CATALENT ANAG NO S.R.L. (PACKAGING , QUALITY CONTROL AND BATCH RELEASE), ITALY/ PFIZER MANUFACTURING DEUTSCHLAND GMBH (PACKAGING, QUALITY CONTROL AT BATCH RELEASE AND BATCH RELEASE), GERMANY/ PFIZER IRELAND PHARMACEUTICALS (MANUFACTURING, CONTROL HOW AUSTI AT BATCH RELEASE), IRELAND/ SORDZ LABORATORIES T/A BRISTOL -MYERS SQUIBB PHARMACEUTICAL OPERATIONS, EXTERNAL MANUFACTURING (SERIES ISSUE), IRELAND
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
UNITED STATES |
UKRAINE |
0 |
|
1. DRUGS FOR HUMANS, WITHOUT VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: ELIQUIS, FILM-COATED TABLETS, 5 MG OF 10 TABLETS IN BLISTERS OF 6 BLISTERS IN A CARDBOARD PACK / 1 FILM-COATED TABLET CONTAINS 5 MG OF APIXABAN; MANUFACTURED BY BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY (MANUFACTURING, QUALITY CONTROL AND QUALITY CONTROL AT BATCH RELEASE), USA/ CATALENT ANAGNI S.R.L.. (PACKAGING, QUALITY CONTROL AND RELEASE SERIES), ITALY/ PFIZER MANUFACTURING DEUTSCHLAND GMBH (PACKAGING, QUALITY CONTROL AT BATCH RELEASE AND BATCH RELEASE), GERMANY/ PFIZER IRELAND PHARMACEUTICALS (MANUFACTURING, QUALITY CONTROL AT BATCH RELEASE), IRELAND I/ SORDZ LABORATORIES T/A BRISTOL-MYERS SQUIBB PHARMACEUTICAL OPERATIONS , EXTERNAL MANUFACTURING (SERIES RELEASE), IRELAND; ELIFOR, 50 MG LONG-RELEASE TABLETS, 14 TABLETS IN BLISTERS; 2 BLISTERS IN A CARDBOARD BOX / 1 PROLONGED-RELEASE TABLET CONTAINS DESVENLAFAXIN SUCCINATE IN AN AMOUNT EQUIVALENT TO 50 MG OF DESVENLAFAXIN; MANUFACTURED BY PFIZER IRELAND PHARMACEUTICALS (PRODUCTION, PRIMARY AND SECONDARY PACKAGING, QUALITY CONTROL), IRELAND/PFEISER MANUFACTURING DEUTSCHLAND GMBH (PRIMARY AND SECONDARY PACKAGING, SERIES ISSUE), GERMANY
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
IRELAND |
UKRAINE |
0 |
|
1. MEDICINE FOR HUMANS, PACKAGED FOR RETAIL TRADE. SERIES HP4331: ELIQUIS, FILM-COATED TABLETS, 2.5 MG, 10 TABLETS IN BLISTERS; 2 BLISTERS IN A CARDBOARD PACK - 214 UP. SERIES FY3320: ELIQUIS, FILM-COATED TABLETS, 2.5 MG, 10 TABLETS IN A BLISTER; 2 BLISTERS IN A CARDBOARD PACK - 426 U. (ACTIVE INGREDIENT - APIXABAN) MANUFACTURER: PRODUCTION, QUALITY CONTROL AND QUALITY CONTROL AT BATCH RELEASE: BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY, US; PACKAGING, QUALITY CONTROL AT BATCH RELEASE AND BATCH RELEASE: PFIZER MANUFACTURING DEUTSCHLAND GMBH, DE
|
![lock](/assets/img/lock.svg) |
![lock](/assets/img/lock.svg) |
UNITED STATES |
UKRAINE |
0 |